<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Focus (Am Psychiatr Publ)</journal-id>
<journal-id journal-id-type="iso-abbrev">Focus (Am Psychiatr Publ)</journal-id>
<journal-id journal-id-type="pmc">focus</journal-id>
<journal-id journal-id-type="publisher-id">foc</journal-id>
<journal-title-group>
<journal-title>Focus: Journal of Life Long Learning in Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1541-4094</issn>
<issn pub-type="epub">1541-4108</issn>
<publisher>
<publisher-name>American Psychiatric Association</publisher-name>
<publisher-loc>Arlington, VA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31975813</article-id>
<article-id pub-id-type="pmc">6526799</article-id>
<article-id pub-id-type="publisher-id">FOC_20160007</article-id>
<article-id pub-id-type="doi">10.1176/appi.focus.20160007</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Synthesis</subject>
</subj-group>
<subj-group subj-group-type="app-publication-features">
<compound-subject>
<compound-subject-part content-type="code">cm</compound-subject-part>
<compound-subject-part content-type="label">CME</compound-subject-part>
</compound-subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Review of Childhood-Onset Schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kendhari</surname>
<given-names>Jusleen</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shankar</surname>
<given-names>Ravi</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Young-Walker</surname>
<given-names>Laine</given-names>
</name>
<degrees>M.D.</degrees>
</contrib>
<aff id="aff1">The authors are with the Department of Clinical Psychiatry, Child and Adolescent Psychiatry, University of Missouri—Columbia, Columbia, MO. </aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Send correspondence to Dr. Kendhari (e-mail: <email xlink:href="kendharij@health.missouri.edu">kendharij@health.missouri.edu</email>).</corresp>
<fn fn-type="COI-statement" id="fn2">
<p>The authors report no financial relationships with commercial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
<string-date>Summer 2016</string-date>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>7</month>
<year>2016</year>
</pub-date>
<volume>14</volume>
<issue>3</issue>
<issue-title>Schizophrenia: Advances in Understanding and Treatment</issue-title>
<fpage>328</fpage>
<lpage>332</lpage>
<permissions>
<copyright-statement>Copyright © by the American Psychiatric Association</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="appi.focus.20160007.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>Schizophrenia is a neurodevelopmental disorder with a multifactorial etiology. Pediatric schizophrenia consists of early-onset schizophrenia (onset prior to age 18 years) and childhood-onset schizophrenia (onset prior to age 13 years). Adolescence has been established as a critical period for neuronal pruning; hence, with earlier the onset of symptoms, there may be disruption in the normal process of neuronal development, causing impairments with memory, abstract thinking, and emotion regulation. Although the lifetime prevalence of schizophrenia is 1% in the general population, the incidence of pediatric schizophrenia is rare. Therefore, it is important to effectively evaluate the cause of any psychosis of a child or an adolescent. An accurate history and physical, including a detailed neurological examination, are vitally important, as are pertinent laboratory and imaging tests to rule out the many alternative differential diagnoses that also present with psychotic symptoms. The antipsychotics continue to be significantly more effective than placebo in treating pediatric schizophrenia in combination with psychotherapy, as evidenced by the recent Recover After an Initial Schizophrenia Episode (RAISE) study. However, further study is still needed to better understand causality, improve assessment, and develop a definitive treatment algorithm.</p>
</abstract>
<counts>
<fig-count count="0"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="30"></ref-count>
<page-count count="5"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name> DJS Export </meta-name>
<meta-value>v1</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>